Peter Langecker's Net Worth
-$11.9 Thousand
Who is Peter Langecker?
Peter Langecker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DURECT CORP, XCYTE THERAPIES INC, OXIGENE INC, and INTARCIA THERAPEUTICS, INC.
SEC CIK
Peter Langecker's CIK is 0001282829
Past Insider Trading and Trends
2009 was Peter Langecker's most active year for acquiring shares with 5 total transactions. Peter Langecker's most active month to acquire stocks was the month of December. 2013 saw Peter Langecker paying a total of $13,822.00 for 86,326 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DURECT CORP (DRRX) Snapshot price: $1.5699
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XCYTE THERAPIES INC (CYCC) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +150.00% | 3K |
$1.88 | $5,627.70 | 5K |
Feb 4
| |||
Form 4
|
∞
| 2K |
$4.25 | $8,500.00 | 2K |
Jun 22 - Jun 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OXIGENE INC (OTLC) Snapshot price: $0.02296
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,459.86% | 72.99K |
—
|
—
| 77.99K |
Aug 8
| |||
Form 4
| +150.00% | 3K |
$2.75 | $8,250.00 | 5K |
Jun 28
| |||
Form 4
|
∞
| 2K |
$2.79 | $5,572.00 | 2K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTARCIA THERAPEUTICS, INC No price found
VP Research & Chief M.O.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||